Douglas P Clark

Author PubWeight™ 48.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 2013 5.71
2 Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003 2.42
3 The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 2008 2.05
4 Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 2011 1.85
5 Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010 1.81
6 Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol 2012 1.81
7 Biospecimen reporting for improved study quality (BRISQ). J Proteome Res 2011 1.48
8 Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 2004 1.47
9 Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Clin Gastroenterol 2006 1.38
10 Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila) 2011 1.27
11 A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 2008 1.27
12 Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod Pathol 2005 1.26
13 Beyond the suspicious thyroid fine needle aspirate. A review. Acta Cytol 2003 1.18
14 Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank 2011 1.12
15 Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration. Cancer Cytopathol 2011 1.11
16 The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol 2010 1.10
17 DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis. Cancer 2004 1.10
18 Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res 2008 1.05
19 Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory. Obstet Gynecol 2011 0.99
20 NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol 2010 0.97
21 Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration. Cancer Cytopathol 2010 0.95
22 Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer 2006 0.95
23 Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'. Acta Cytol 2011 0.94
24 Methylation profiling of benign and malignant breast lesions and its application to cytopathology. Mod Pathol 2003 0.93
25 C-fos assessment as a marker of anti-epidermal growth factor receptor effect. Cancer Res 2006 0.93
26 Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008 0.90
27 DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma. Clin Cancer Res 2005 0.90
28 Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol 2003 0.87
29 Three-gene molecular diagnostic model for thyroid cancer. Thyroid 2012 0.85
30 Functional profiling of live melanoma samples using a novel automated platform. PLoS One 2012 0.83
31 Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res 2004 0.83
32 Methylation profiling of mesothelioma using real-time methylation-specific PCR: a pilot study. Diagn Cytopathol 2007 0.82
33 Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest 2010 0.82
34 Host cell fate on Cryptosporidium parvum egress from MDCK cells. Infect Immun 2003 0.81
35 Methylation profiling of urothelial carcinoma in bladder biopsy and urine. Acta Cytol 2006 0.80
36 Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling. Hum Pathol 2008 0.80
37 Analysis of nondiagnostic results after image-guided needle biopsies of musculoskeletal lesions. Clin Orthop Relat Res 2010 0.79
38 A break-apart fluorescence in situ hybridization assay for detecting RET translocations in papillary thyroid carcinoma. Cancer Genet Cytogenet 2007 0.77
39 An unusual case of recurrent hyperparathyroidism and papillary thyroid cancer. Endocr Pract 2009 0.76
40 Molecular diagnostics on thyroid fine-needle aspirations: the pathway to value creation. Cancer Cytopathol 2010 0.75
41 Particle disease: cytopathologic findings of an unusual case. Diagn Cytopathol 2004 0.75
42 Validation of a low-cost, liquid-based screening method for cervical intraepithelial neoplasia. Am J Obstet Gynecol 2006 0.75
43 Reed-Sternberg-like cells in lymph node aspirates in the absence of Hodgkin's disease: pathologic significance and differential diagnosis. Diagn Cytopathol 2002 0.75
44 Detection of DNA methylation. Potential applications to diagnostic cytopathology. Acta Cytol 2003 0.75